Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806021 | SCV000946001 | uncertain significance | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-11-15 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 1099 of the COL12A1 protein (p.Thr1099Asn). This variant is present in population databases (rs768943327, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of COL12A1-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 650797). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt COL12A1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001776020 | SCV002012666 | uncertain significance | not provided | 2023-09-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |